XML 52 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Stock Option Activity

The following table summarizes stock option activity for the three months ended March 31, 2013:

 

     Number of
Options
    Weighted
Average
Exercise Price
    Weighted
Average
Remaining
Contractual Term
(in years)
    Aggregate Intrinsic
Value (1)
 

Outstanding at December 31, 2012

     7,038,291      $ 18.90       

Granted

     37,200      $ 52.46       

Exercised

     (177,815   $ 10.25       

Forfeited

     —          —         
  

 

 

       

Outstanding at March 31, 2013

     6,897,676      $ 19.31        7.09      $ 195.7   
  

 

 

       

Vested and exercisable at March 31, 2013

     3,908,361      $ 11.12        5.86      $ 139.3   
  

 

 

       

 

(1) 

The aggregate intrinsic value is calculated as the pre-tax difference between the weighted average exercise price of the underlying awards and the closing price per share of $46.76 of the Company’s common stock on March 28, 2013. The calculation excludes any awards with an exercise price higher than the closing price of the Company’s common stock on March 28, 2013. The amounts are presented in millions.

Summary of Restricted Stock Units

The following table summarizes restricted stock unit activity for the three months ended March 31, 2013:

 

     Number of
Shares
     Weighted-
Average
Grant-Date
Fair Value
 

Unvested at December 31, 2012

     373,625       $ 39.06   

Granted

     9,600       $ 53.66   

Vested

     —           —     

Forfeited

     —           —     
  

 

 

    

Unvested at March 31, 2013

     383,225       $ 39.43   
Summary of Stock Appreciation Rights Activity

The following table summarizes stock appreciation rights activity for the three months ended March 31, 2013:

 

    Number of
Rights
    Weighted
Average
Exercise Price
    Weighted
Average
Remaining
Contractual Term
(in years)
    Aggregate Intrinsic
Value (1)
 

Outstanding at December 31, 2012

    883,600      $ 23.91       

Granted

    —          —         

Exercised

    (9,508   $ 23.20       

Forfeited

    —          —         
 

 

 

       

Outstanding at March 31, 2013

    874,092      $ 23.92        8.73      $ 20.0   
 

 

 

       

Vested and exercisable at March 31, 2013

    259,144      $ 23.96        8.72      $ 5.9   
 

 

 

       

 

(1) 

The aggregate intrinsic value is calculated as the pre-tax difference between the weighted average exercise price of the underlying awards and the closing price per share of $46.76 of the Company’s common stock on March 28, 2013. The calculation excludes any awards with an exercise price higher than the closing price of the Company’s common stock on March 28, 2013. The amounts are presented in millions.

Schedule of Black-Scholes Assumptions Used for Stock Options and Stock Appreciations Rights

The Company estimated the fair value of stock options and stock appreciation rights using the Black-Scholes valuation model, which requires the use of subjective assumptions related to the estimated stock price volatility, estimated term, estimated dividend yield and risk-free interest rate. The Black-Scholes assumptions used for stock options and stock appreciations rights granted and/or remeasured were as follows:

 

     Three Months Ended
March 31,
 
     2013     2012  

Risk-free interest rate

     0.93-0.94     0.99-1.18

Estimated term (in years)

     5.24        5.48   

Estimated volatility

     68     73

Estimated dividend yield

     —          —     
Schedule of Stock-Based Compensation Expense

Stock-based compensation expense was as follows:

 

     Three Months Ended
March 31,
 
     2013      2012  

Stock-based compensation expense recognized as:

  

R&D

   $ 3,818       $ 2,437   

SG&A

     4,478         1,899   
  

 

 

    

 

 

 

Total

   $ 8,296       $ 4,336